Clinical Trials Logo

Filter by:
NCT ID: NCT04326101 Completed - Heart Failure Clinical Trials

Electronic Transmission of Laboratory and Adherence Records of Heart Failure Patients to General Practitioners Screen

LabAdhDoc
Start date: August 15, 2020
Phase:
Study type: Observational

Patients with heart failure (HF) need multiple guideline-directed medications to control the systolic and/or diastolic ventricular dysfunction. Laboratory measure the biomarker NT-proBNP (N-terminal pro-B type natriuretic peptide) to support clinical decision and to guide treatment at every stage of HF. Many patients (including HF patients) do not follow therapeutic recommendations. Electronic monitoring of medication intake gives precise information over time and is the gold standard to unveil inappropriate behaviour. Electronic Health Records (EHR) are repository of patient health data in digital format and are mostly locally configured in medical practices. We aim to transmit laboratory results of NT-proBNP and estimates of medication adherence into the EHR system of primary care providers, with the objective to guide treatment and dose adjustment of multiple medications in patients with HF. Our project is *not* to develop a telemonitoring system.

NCT ID: NCT04321785 Completed - Caffeine Clinical Trials

Effects of Caffeine on Sleep-wake Regulation in Teenagers

Start date: April 13, 2018
Phase: N/A
Study type: Interventional

The aim is to quantify the effects of one dose of caffeine (compared to placebo) on sleep and wakefulness in adolescents.

NCT ID: NCT04318405 Completed - Iron-Deficiency Clinical Trials

Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).

Real-CHOICE
Start date: July 10, 2020
Phase:
Study type: Observational

Real-CHOICE - designed as a prospective, longitudinal, observational, non-interventional study - will investigate the attitude of patients and physicians towards IV (intravenous) iron therapy in general and IIM (iron isomaltoside 1000) treatment particularly before and after IIM treatment in iron deficient patients with or without anemia in the real-world clinical setting after commercial availability of this product in Switzerland.

NCT ID: NCT04318236 Completed - Depression Moderate Clinical Trials

Factorial Trial Investigating Outcome and Adherence Relevant Factors in an Online Self-help Intervention for Depression

HERMES
Start date: March 3, 2020
Phase: N/A
Study type: Interventional

A vast amount of studies show that online interventions are suitable to reduce symptoms of mental illness as for instance depression or anxiety. However, participants who use online interventions are more likely to drop out of treatment compared to face-to-face interventions. It is important to enhance adherence to online interventions so that participants engage longer in the programs. Also, as online interventions are useful to reduce the burden of mental illness, it is of interest to further improve outcomes of such interventions. Therefore, it will be investigated in this study whether or not four different factors have an impact in fostering adherence to and improving outcome of an internet-based self-help intervention based on problem-solving therapy. A multifactorial design will be used for this study to screen simultaneously whether or not i) a diagnostic telephone interview and, ii) an educational module based on motivational interviewing prior to the intervention and iii) guidance by the study team, and iv) automated e-mail reminders during the study are active factors in enhancing adherence to and outcome of online interventions.

NCT ID: NCT04315636 Completed - Preterm Birth Clinical Trials

Surfactant Nebulization for the Early Aeration of the Preterm Lung

SUNSET
Start date: March 19, 2021
Phase: Phase 3
Study type: Interventional

Respiratory distress syndrome is the most common cause of respiratory failure in preterm infants. Treatment consists of respiratory support and exogenous surfactant administration. Commonly, surfactant is administered via an endotracheal tube during mechanical ventilation. However, mechanical ventilation is considered an important risk factor for developing bronchopulmonary dysplasia. Surfactant nebulisation during noninvasive ventilation may offer an alternative method for surfactant administration and has been shown to be promising in terms of physiological as well as clinical changes. In preterm infants with respiratory distress syndrome, the effect of intratracheally administered surfactant on lung function during invasive ventilation has been studied extensively. However, the effect of early postnatal surfactant nebulization remains unclear. Therefore, the investigators plan to conduct a randomized controlled trial in order to investigate the effect of surfactant nebulization immediately after birth on early postnatal lung volume and short-term respiratory stability.

NCT ID: NCT04314999 Completed - Clinical trials for Chronic Spontaneous Urticaria

Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria

Start date: June 1, 2019
Phase:
Study type: Observational

The goal of this study is to describe the prevalence and the type of parasite in patients with a chronic spontaneous urticaria as well as to describe the associations between parasitic disease and the characteristics of the patients, for example eosinophilia.

NCT ID: NCT04310124 Completed - Clinical trials for Blood Loss, Surgical

Comparison of the ROTEM Sigma and the Quantra System in Cardiac Surgery

Start date: December 17, 2018
Phase:
Study type: Observational

This study compares the results of the Quantra System with the QPlus Cartridge to results obtained with the ROTEM sigma in patients undergoing cardia surgery utilizing cardiopulmonary bypass.

NCT ID: NCT04309994 Completed - Heart Attack Clinical Trials

Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction

Start date: February 1, 2010
Phase:
Study type: Observational

The goal of this study is to compare the two cardioplegia solutions (blood cardioplegia by means of MPS ® vs. Cardioplexol ®) regarding perioperative outcome and with special attention to cardiac markers in patients with a recent heart attack.

NCT ID: NCT04309591 Completed - Endocarditis Clinical Trials

Cytosorb Therapy in Cardiac Surgery

Start date: October 18, 2019
Phase:
Study type: Observational

Cardiopulmonary surgery is associated with inflammatory responses that can lead to systemic inflammatory responses (SIRS), organ dysfunction (MOD) and death especially in patients with endocarditis. Cytokine removal might therefore improve outcomes of patients undergoing cardiac surgery. CytoSorb is a device designed to remove cytokine (IL-6, IL-10, TNFalpha) from the blood to reduce immune reactions. This trial investigates the use of CytoSorb during cardiac surgery in patients with endocarditis at the University Hospital Basel.

NCT ID: NCT04308642 Completed - Kidney Impairment Clinical Trials

Study to Evaluate Blood and Urine Kidney Injury Markers to Facilitate Early Detection of Renal Adverse Drug Events in Pediatric Cancer Patients Treated With Nephrotoxic Chemotherapy

Kid-MaCareOnco
Start date: October 22, 2020
Phase:
Study type: Observational

This study is to investigate blood and urine kidney injury markers (especially Uromodulin) in pediatric cancer patients treated with nephrotoxic chemotherapy. Uromodulin is a marker to detect and monitor tubular injury and renal function.